Make scientific figures in minutes
Create publication-quality figures with pre-made icons and templates, all from BioRender's web-based software
Use Icons In The App
Try a synonym, or sign up to request an icon from the app.
VEGFR3
[{"image":"https://icons.cdn.biorender.com/w75xh75/6051101cebe3a10026503c53/60510f73ebe3a10026503c2e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6051101cebe3a10026503c53/60510f73ebe3a10026503c2e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6051101cebe3a10026503c52/60510f73ebe3a10026503c2e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6051101cebe3a10026503c52/60510f73ebe3a10026503c2e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6051101cebe3a10026503c51/60510f73ebe3a10026503c2e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6051101cebe3a10026503c51/60510f73ebe3a10026503c2e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6051101cebe3a10026503c50/60510f73ebe3a10026503c2e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6051101cebe3a10026503c50/60510f73ebe3a10026503c2e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6051101cebe3a10026503c4f/60510f73ebe3a10026503c2e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6051101cebe3a10026503c4f/60510f73ebe3a10026503c2e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6051101cebe3a10026503c4e/60510f73ebe3a10026503c2e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6051101cebe3a10026503c4e/60510f73ebe3a10026503c2e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6051101cebe3a10026503c4d/60510f73ebe3a10026503c2e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6051101cebe3a10026503c4d/60510f73ebe3a10026503c2e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6051101cebe3a10026503c4c/60510f73ebe3a10026503c2e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6051101cebe3a10026503c4c/60510f73ebe3a10026503c2e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6051101cebe3a10026503c4b/60510f73ebe3a10026503c2e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6051101cebe3a10026503c4b/60510f73ebe3a10026503c2e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6051101cebe3a10026503c4a/60510f73ebe3a10026503c2e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6051101cebe3a10026503c4a/60510f73ebe3a10026503c2e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6051101cebe3a10026503c49/60510f73ebe3a10026503c2e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6051101cebe3a10026503c49/60510f73ebe3a10026503c2e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6051101cebe3a10026503c48/60510f73ebe3a10026503c2e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6051101cebe3a10026503c48/60510f73ebe3a10026503c2e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6051101cebe3a10026503c47/60510f73ebe3a10026503c2e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6051101cebe3a10026503c47/60510f73ebe3a10026503c2e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6051101cebe3a10026503c46/60510f73ebe3a10026503c2e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6051101cebe3a10026503c46/60510f73ebe3a10026503c2e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6051101cebe3a10026503c45/60510f73ebe3a10026503c2e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6051101cebe3a10026503c45/60510f73ebe3a10026503c2e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6051101cebe3a10026503c44/60510f73ebe3a10026503c2e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6051101cebe3a10026503c44/60510f73ebe3a10026503c2e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6051101cebe3a10026503c43/60510f73ebe3a10026503c2e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6051101cebe3a10026503c43/60510f73ebe3a10026503c2e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6051101cebe3a10026503c42/60510f73ebe3a10026503c2e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6051101cebe3a10026503c42/60510f73ebe3a10026503c2e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6051101cebe3a10026503c41/60510f73ebe3a10026503c2e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6051101cebe3a10026503c41/60510f73ebe3a10026503c2e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6051101cebe3a10026503c40/60510f73ebe3a10026503c2e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6051101cebe3a10026503c40/60510f73ebe3a10026503c2e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6051101cebe3a10026503c3f/60510f73ebe3a10026503c2e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6051101cebe3a10026503c3f/60510f73ebe3a10026503c2e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6051101cebe3a10026503c3e/60510f73ebe3a10026503c2e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6051101cebe3a10026503c3e/60510f73ebe3a10026503c2e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6051101cebe3a10026503c3d/60510f73ebe3a10026503c2e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6051101cebe3a10026503c3d/60510f73ebe3a10026503c2e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6051101cebe3a10026503c3c/60510f73ebe3a10026503c2e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6051101cebe3a10026503c3c/60510f73ebe3a10026503c2e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6051101cebe3a10026503c3b/60510f73ebe3a10026503c2e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6051101cebe3a10026503c3b/60510f73ebe3a10026503c2e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6051101cebe3a10026503c3a/60510f73ebe3a10026503c2e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6051101cebe3a10026503c3a/60510f73ebe3a10026503c2e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6051101cebe3a10026503c39/60510f73ebe3a10026503c2e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6051101cebe3a10026503c39/60510f73ebe3a10026503c2e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6051101cebe3a10026503c38/60510f73ebe3a10026503c2e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6051101cebe3a10026503c38/60510f73ebe3a10026503c2e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6051101cebe3a10026503c37/60510f73ebe3a10026503c2e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6051101cebe3a10026503c37/60510f73ebe3a10026503c2e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6051101cebe3a10026503c36/60510f73ebe3a10026503c2e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6051101cebe3a10026503c36/60510f73ebe3a10026503c2e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6051101cebe3a10026503c35/60510f73ebe3a10026503c2e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6051101cebe3a10026503c35/60510f73ebe3a10026503c2e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6051101cebe3a10026503c34/60510f73ebe3a10026503c2e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6051101cebe3a10026503c34/60510f73ebe3a10026503c2e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6051101cebe3a10026503c33/60510f73ebe3a10026503c2e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6051101cebe3a10026503c33/60510f73ebe3a10026503c2e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6051101cebe3a10026503c32/60510f73ebe3a10026503c2e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6051101cebe3a10026503c32/60510f73ebe3a10026503c2e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6051101cebe3a10026503c31/60510f73ebe3a10026503c2e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6051101cebe3a10026503c31/60510f73ebe3a10026503c2e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6051101cebe3a10026503c30/60510f73ebe3a10026503c2e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6051101cebe3a10026503c30/60510f73ebe3a10026503c2e.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6051101cebe3a10026503c2f/60510f73ebe3a10026503c2e.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6051101cebe3a10026503c2f/60510f73ebe3a10026503c2e.png"}]
Use this icon in BioRender along with 1000s of others to make your next science figure in minutes
.png)
SIGN UP FREEKeywords
VEGF receptor,VEGFR3,vascular endothelial growth factor 3,vascular permeability factor 3,VPF3,VEGF,membrane bound,mbVEGFR,soluble,sVEGFR,monomer,growth factor,platelet-derived growth factor,cystine-knot,vasculogenesis,vascular endothelium,mitogenesis,cell migration,microvascular permeability,tyrosine kinase,transphosphorylation,immunoglobulin-like domains,VEGFR3
Image types
BioRender icons and templates meet journal, grant, and copyright standards. For AI-generated figures, policies vary. Learn More
Related Categories
Join 1,500,000 other scientists on BioRender
Sign up for your free account and start creating scientific figures faster today
FAQs
What is BioRender?
Can I use this icon in a BioRender figure or scientific illustration?
